Arrayit patented and proprietary microarray-based biomarker discovery program and PDx™ Parkinsons Disease Companion Diagnostic Test can greatly reduce the cost of PD drug discovery by pinpointing molecular pathways in advance of costly clinical trials https://t.co/0ATGxgQz0jhttps://t.co/410lrBHT1e